Zepp Health [ZEPP] vs Sonos [SONO] Detailed Stock Comparison
Zepp Health
NYSE
Loading...
Sonos
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: Zepp Health wins in 9 metrics, Sonos wins in 9 metrics, with 0 ties. Both stocks appear equally matched on key metrics.
View Metrics Details
Vital Metrics Comparison
| Metric | Zepp Health | Sonos | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -5.31 | 142.45 | Zepp Health |
| Price-to-Book Ratio | 1.57 | 3.41 | Zepp Health |
| Debt-to-Equity Ratio | 47.49 | 16.46 | Sonos |
| PEG Ratio | -2,239.00 | -72.47 | Zepp Health |
| EV/EBITDA | -105.68 | 48.63 | Zepp Health |
| Profit Margin (TTM) | -38.81% | -4.74% | Sonos |
| Operating Margin (TTM) | -10.27% | -14.45% | Zepp Health |
| Return on Equity | -28.32% | -15.80% | Sonos |
| Return on Assets (TTM) | -5.10% | -2.55% | Sonos |
| Free Cash Flow (TTM) | $-25.88M | $134.66M | Sonos |
| 1-Year Return | 870.70% | -5.11% | Zepp Health |
| Price-to-Sales Ratio (TTM) | 1.61 | 0.89 | Sonos |
| Enterprise Value | $4.47B | $1.14B | Zepp Health |
| EV/Revenue Ratio | 22.34 | 0.78 | Sonos |
| Gross Profit Margin (TTM) | 37.27% | 43.74% | Sonos |
| Revenue per Share (TTM) | $12 | $12 | Zepp Health |
| Earnings per Share (Diluted) | $-4.80 | $-0.56 | Sonos |
| Beta (Stock Volatility) | 1.12 | 2.04 | Zepp Health |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Zepp Health vs Sonos Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Zepp Health | 2.26% | 91.15% | 385.35% | 834.21% | 771.93% | 765.85% |
| Sonos | 3.28% | 9.36% | 5.30% | 15.14% | -17.90% | -23.13% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Zepp Health | 870.70% | 204.53% | -57.45% | -45.41% | -45.41% | -45.41% |
| Sonos | -5.11% | -34.01% | -19.30% | -45.92% | -45.92% | -45.92% |
Performance & Financial Health Analysis: Zepp Health vs Sonos
| Metric | ZEPP | SONO |
|---|---|---|
| Market Information | ||
| Market Cap | $321.70M | $1.31B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 333,011 | 2,188,490 |
| 90 Day Avg. Volume | 1,044,594 | 1,799,613 |
| Last Close | $24.85 | $11.33 |
| 52 Week Range | $2.12 - $27.86 | $7.63 - $15.89 |
| % from 52W High | -10.80% | -28.70% |
| All-Time High | $81.00 (Feb 15, 2021) | $44.72 (Apr 12, 2021) |
| % from All-Time High | -69.32% | -74.66% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.46% | 0.03% |
| Quarterly Earnings Growth | 5.89% | 0.03% |
| Financial Health | ||
| Profit Margin (TTM) | -0.39% | -0.05% |
| Operating Margin (TTM) | -0.10% | -0.14% |
| Return on Equity (TTM) | -0.28% | -0.16% |
| Debt to Equity (MRQ) | 47.49 | 16.46 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $14.22 | $3.19 |
| Cash per Share (MRQ) | $0.22 | $1.86 |
| Operating Cash Flow (TTM) | $-25,970,000 | $122.26M |
| Levered Free Cash Flow (TTM) | $-134,703,985 | $120.99M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | $0.00 | N/A |
Valuation & Enterprise Metrics Analysis: Zepp Health vs Sonos
| Metric | ZEPP | SONO |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -5.31 | 142.45 |
| Forward P/E | -2,239.00 | -72.47 |
| PEG Ratio | -2,239.00 | -72.47 |
| Price to Sales (TTM) | 1.61 | 0.89 |
| Price to Book (MRQ) | 1.57 | 3.41 |
| Market Capitalization | ||
| Market Capitalization | $321.70M | $1.31B |
| Enterprise Value | $4.47B | $1.14B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 22.34 | 0.78 |
| Enterprise to EBITDA | -105.68 | 48.63 |
| Risk & Other Metrics | ||
| Beta | 1.12 | 2.04 |
| Book Value per Share (MRQ) | $14.22 | $3.19 |
Financial Statements Comparison: Zepp Health vs Sonos
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ZEPP | SONO |
|---|---|---|
| Revenue/Sales | $38.54M | $259.76M |
| Cost of Goods Sold | $24.18M | $146.15M |
| Gross Profit | $14.36M | $113.61M |
| Research & Development | $12.38M | $77.42M |
| Operating Income (EBIT) | $-18.38M | $-54.23M |
| EBITDA | $-17.79M | $-36.89M |
| Pre-Tax Income | $-19.27M | $-59.17M |
| Income Tax | $110,000 | $10.98M |
| Net Income (Profit) | $-19.74M | $-70.14M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ZEPP | SONO |
|---|---|---|
| Cash & Equivalents | $76.43M | $173.16M |
| Total Current Assets | $242.46M | $453.02M |
| Total Current Liabilities | $212.34M | $289.59M |
| Long-Term Debt | $71.16M | $56.44M |
| Total Shareholders Equity | $232.04M | $382.86M |
| Retained Earnings | $8.88M | $-70.84M |
| Property, Plant & Equipment | $9.56M | $335.68M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ZEPP | SONO |
|---|---|---|
| Operating Cash Flow | $-14.63M | $23.62M |
| Capital Expenditures | $-2.92M | $-5.56M |
| Free Cash Flow | $-16.89M | $-65.22M |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | $-40.64M |
Short Interest & Institutional Ownership Analysis
| Metric | ZEPP | SONO |
|---|---|---|
| Shares Short | 308,546 | 7.66M |
| Short Ratio | 0.25 | 4.62 |
| Short % of Float | 0.05% | 0.09% |
| Average Daily Volume (10 Day) | 333,011 | 2,188,490 |
| Average Daily Volume (90 Day) | 1,044,594 | 1,799,613 |
| Shares Outstanding | 231.98M | 121.76M |
| Float Shares | 108.71M | 102.88M |
| % Held by Insiders | 0.06% | 0.02% |
| % Held by Institutions | 0.26% | 0.96% |
Dividend Analysis & Yield Comparison: Zepp Health vs Sonos
| Metric | ZEPP | SONO |
|---|---|---|
| Last 12-Month Dividend | $0.00 | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | $0.00 | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | $0.00 | N/A |
| Ex-Dividend Date | N/A | N/A |